96729 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides containing heteroatoms different from O, S, or N
Protease inhibitors
#2Solution phase synthesis of β-turn peptidomimetic cyclic salts
#3OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#4PROCESS AND INTERMEDIATES FOR SYNTHESIS OF PEPTIDE COMPOUNDS
#5Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#6Solution phase synthesis of beta-turn peptidomimetic cyclic salts
#7Methods for the synthesis of arginine-containing peptides
#8OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#918F labeled amino acids, derivatives thereof and method of making same
#10Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
#11Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells
#12Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#13Peptidomimetics for imaging the ghrelin receptor
#14Melanocortin ligands and methods of use thereof
#15Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
#16FLUORINATED EPOXYKETONE-BASED TETRAPEPTIDE COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS
#17Peptoids useful for the mineralization of apatite
#18Smart pro-drugs of serine protease inhibitors
#1999mTc-LABELED TRIPHENYLPHOSPHONIUM DERIVATIVE CONTRASTING AGENTS AND MOLECULAR PROBES FOR EARLY DETECTION AND IMAGING OF BREAST TUMORS
#20Quinoxaline-containing compounds as hepatitis C virus inhibitors
#21INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE
#22REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF
#23Peptidic compounds
#24METAL-BINDING COMPOUNDS AND USES THEREFOR
#25Michael systems as transglutaminase inhibitors
#26Metal-binding compounds and uses therefor
#27Metal-binding compounds and uses therefor
#28Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#29Metal-binding compounds and uses therefor
#30INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
#31Smart Pro-Drugs of Serine Protease Inhibitors
#32Metal-binding compounds and uses therefor
#33REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF
#34Regulation of autophagy pathway phosphorylation and uses thereof
#35Quinoxaline-containing compounds as hepatitis C virus inhibitors
#3699m Tc-labeled triphenylphosphonium derivative contrasting agents and molecular probes for early detection and imaging of breast tumors
#37Fluorinated tripeptide HCV serine protease inhibitors
#38METHOD FOR PREPARING LYSOBACTIN DERIVATIVES
#39Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
#40Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#41Peptidic compounds
#42Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#43Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#44Inhibitors of serine proteases, particular HCV NS3-NS4A protease
#45Collections of Traceable Compounds and Uses Thereof
#46Modulators of beta-amyloid peptide aggregation comprising D-amino acids
#47Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis
#48Compounds for inhibiting cathepsin activity
#49Potent and specific immunoproteasome inhibitors
#50Method of screening groups of radioactive molecules and applications thereof
#51Melanocortin receptor ligands
#52Smart pro-drugs of serine protease inhibitors
#53Opioid metallopeptide compositions and methods
#54Modulators of β-amyloid peptide aggregation comprising D-amino acids
#55Hpma-polyamine conjugates and uses therefore
#56Method of making metallopeptides
#57Methods for inhibiting angiogenesis and or lymphangiogenesis
#58Immunopotentiators
#59Metal-binding compounds and uses therefor
#60Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy
#61Opioid metallopeptide compositions and methods
#62Methods and compositions for derepression of IAP-inhibited caspase
#63Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#64Methods and compositions for derepression of IAP-inhibited caspase
#65Linear and cyclic melanocortin receptor-specific peptides